QCM Cayman, Ltd.

SEC CIK: 0001166340
Latest filing: Nov 4, 2024

SEC filings (opens in a new tab)

ODT holding history

Odonate Therapeutics, Inc. in every 13F filed by QCM Cayman, Ltd., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ODT overview All 13F holders of ODT Full Q3 2024 holdings

Shares (Q2 2021): 0; Sold out in Q2 2021
Value: $0
% of portfolio: 0.0%
Quarters held: 1; Since Q1 2021

Holdings of ODT by QCM Cayman, Ltd., by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2021	0	$0	0.0%	−15,478−100.0%	Sold out	Holders
Q1 2021	15,478	$53.0K	0.2%	–	–	Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.